Harrow, Inc. (HROW)
52.74
+1.19
(+2.31%)
USD |
NASDAQ |
Feb 24, 16:00
52.90
+0.16
(+0.30%)
After-Hours: 19:55
Harrow Research and Development Expense (Quarterly) : 3.323M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 68.85M |
| Assertio Holdings, Inc. | 0.379M |
| CapsoVision, Inc. | 6.09M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |